A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Juvenile
  • Interleukin 1 Receptor Antagonist Protein

abstract

  • NCT00339157.

publication date

  • May 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3070271

Digital Object Identifier (DOI)

  • 10.1136/ard.2010.134254

PubMed ID

  • 21173013

Additional Document Info

start page

  • 747

end page

  • 54

volume

  • 70

number

  • 5